| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 05/25/2005 | CN1202843C Narcotic medical composition, preparing process and use thereof |
| 05/24/2005 | US6897321 Process for preparing azacycloalkanoylaminothiazoles (LD 137e) |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107436 Compounds for inflammation and immune-related uses |
| 05/19/2005 | US20050107435 antibiotics such as (5S,5S')-N-(3-{4'-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,2'-difluoro-biphenyl-4-yl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide, used for treating a bacterial infections in mammals |
| 05/19/2005 | US20050107346 Synergistic treatment, better effects on solid tumours; with a mixture of a platinum anticancer agents and a taxane, with ionizing radiation therapy |
| 05/19/2005 | US20050107337 Platinum complexes having antitumor activity |
| 05/18/2005 | CN1617723A Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 05/18/2005 | CN1202108C Spiro compounds, preparing method and intermediate |
| 05/17/2005 | US6894058 Administering statin drug |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | CA2350061C New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP1140124B1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/04/2005 | EP1527787A1 Immediate release tablet |
| 04/28/2005 | WO2004075988A3 Methods of immunomodulation in animals |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050089478 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | CN1610679A Efficient process for the preparation of a factor XA inhibitor |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/21/2005 | WO2005000405A3 P38 kinase inhibitor compositions and methods of use |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 04/19/2005 | US6881743 Pyridine matrix metalloproteinase inhibitors |
| 04/13/2005 | CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/13/2005 | CN1196488C Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/07/2005 | US20050075369 Novel form of S-omeprazole |
| 04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 04/06/2005 | CN1604780A Use of rosuvastatin in pre demented states |
| 04/06/2005 | CN1604777A Method of treatment |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/05/2005 | US6875446 Method for prophylaxis and/or treatment of thromboembolism |
| 03/30/2005 | EP1517710A1 Pegylated factor vii glycoforms |
| 03/30/2005 | EP1517679A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/30/2005 | CN1602299A Crystals of bicalutamide and process for their production |
| 03/30/2005 | CN1602197A Use of specific dose of fondaparinux sodium for the treatment of ACS |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872707 Prevention, therapy of bacteria infections |
| 03/24/2005 | US20050065209 Citalopram for the treatment of elevated blood pressure |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/23/2005 | EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells |
| 03/23/2005 | EP1027064B1 A process for the removal of undersired toxic alkaloids from plants or from vegetable preparations |
| 03/23/2005 | CN1599605A Pharmaceutical compositions and methods for administering EP2 receptor selective agonists |
| 03/23/2005 | CN1599601A Plaster for the treatment of dysfunctions and disorders of nails |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869625 Administering an effective amount of an Argyrolobium roseum extract containing flavonoid glycoside compound for therapy of hyperglycemia non-insulin dependent diabetes mellitus in an animal |
| 03/16/2005 | EP1513800A1 N-benzoylureidocinnamate derivatives, method for production and use thereof |
| 03/16/2005 | CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
| 03/16/2005 | CN1192798C Vaccine |
| 03/10/2005 | US20050053627 Vaccines for Mycoplasma bovis and methods of use |
| 03/09/2005 | EP1511727A2 Aromatic sulfones and their medical use |
| 03/09/2005 | CN1191852C Vaccine |
| 03/02/2005 | EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589147A Use of N-(indolecarbonyl-)piperazine derivatives |
| 03/02/2005 | CN1589140A Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191263C 3-deoxy-desmycosin derivatives and process for their preparation |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043285 Formulation |
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585645A Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine |
| 02/16/2005 | EP1506185A1 Novel compounds and their use |
| 02/16/2005 | EP1505977A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 02/16/2005 | EP1240166B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/10/2005 | WO2004101071A3 Infusion hub assembly and inserter |
| 02/10/2005 | US20050032808 Pyrazine carboxamide compounds for use in treatment of obesity, psychiatric and neurological disorders; for example, N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide |
| 02/10/2005 | US20050031709 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/09/2005 | EP1504019A1 Platinum complexes having antitumor activity |
| 02/09/2005 | EP1098639B1 Use of the glucose uptake enhancer rosiglitazone for reducing ischaemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188128C Triazineone compounds for treating diseases due to sarcosystis neospora and toxoplasma |
| 02/03/2005 | WO2005009954A2 Method for modulating calcium ion-release-activated calcium ion channels |
| 02/03/2005 | WO2005009539A2 Compounds for inflammation and immune-related uses |
| 02/03/2005 | US20050027129 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2005 | US20050026888 Formulation containing anti-inflammatory androstane derivatives |
| 02/03/2005 | CA2533594A1 Compounds for inflammation and immune-related uses |
| 02/02/2005 | EP1502592A1 Controlled release oxycodone compositions |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/02/2005 | CN1187044C Storable active substance concentrate containing formoterol |